Navigation Links
VWR to Hold First Quarter 2012 Financial Results Conference Call
Date:5/7/2012

RADNOR, Pa., May 7, 2012 /PRNewswire/ -- VWR Funding, Inc., the parent company of VWR International, LLC, a leading global laboratory supply and distribution company, will hold a conference call on Thursday, May 10, 2012, to discuss its first quarter 2012 financial results. Who:John M. Ballbach, Chairman, President and CEOGregory L. Cowan, Senior Vice President and CFOWhen:Thursday, May 10, 20129:00 AM Eastern Time (ET)How: 

 

 

Interested parties may participate by dialing (760) 298-5093 or toll free at (877) 845-1003. A replay of the call will be available on Thursday, May 10, 2012 at 12:00 PM ET through Thursday, May 24, 2012 at midnight, by dialing (404) 537-3406 or toll free at (800) 585-8367, pass code for both replay numbers will be 76187966.Information: 

 VWR Funding's Quarterly Report on Form 10-Q for the quarter ended March 31, 2012, will be filed on or before Thursday, May 10, 2012, with the Securities and Exchange Commission.About VWR International, LLC VWR International, LLC, headquartered in Radnor, Pennsylvania, is a global laboratory supply and distribution company with worldwide sales in excess of $4.1 billion in 2011. VWR enables the advancement of the world's most critical research through the distribution of a highly diversified product line to most of the world's top pharmaceutical and biotech companies, as well as industrial, educational and governmental organizations. With 150 years of industry experience, VWR offers a well-established distribution network that reaches thousands of specialized labs and facilities spanning the globe. VWR has over 8,000 associates around the world working to streamline the way researchers across North America, Europe, and Asia stock and maintain their labs. In addition, VWR further supports its customers by providing onsite services, storeroom management, product procurement, supply chain systems integration and technical services.

For more information on VWR, phone 1-800-932-5000, visit www.vwr.com, or write, VWR, Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road, Radnor, PA 19087.

VWR and design are registered trademarks of VWR International, LLC.


'/>"/>
SOURCE VWR Funding, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China Pharma Holdings, Inc. to Report First Quarter of Fiscal Year 2012 Financial Results on May 15, 2012
2. PDL BioPharma Announces First Quarter 2012 Financial Results
3. Verenium Corporation To Announce First Quarter 2012 Financial Results
4. Discovery Labs Reports First Quarter 2012 Financial Results
5. Sangamo BioSciences Reports First Quarter 2012 Financial Results
6. MiMedx Group Announces Record First Quarter Results
7. Innophos Holdings, Inc. Reports First Quarter 2012 Results
8. Sangamo BioSciences Announces First Quarter 2012 Conference Call and Webcast
9. Dyadic International To Release First Quarter 2012 Financial Results And Host Conference Call
10. First atomic-scale real-time movies of platinum nanocrystal growth in liquids
11. Cell Therapeutics, Inc. (CTI) Reports First Quarter Financial Results and Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... UCHealth ( Aurora, Colorado ) ... nodule patient management. In addition to optimizing care coordination ... the lung, UCHealth looks to improve provider workflow by ... Stephanie Brown, RN , Thoracic Nurse Navigator, ... an Excel spreadsheet, which was extremely arduous and susceptible ...
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... 16, 2017  Windtree Therapeutics, Inc. (Nasdaq: ... developing aerosolized KL4 surfactant therapies for respiratory diseases, ... study showed that aerosolized KL4 surfactant reduced lung ... preclinical animal model. The Company believes that these ... evidence that supports the role of KL4 surfactant ...
(Date:2/16/2017)... YORK , Feb. 16, 2017 Paradigm ... Series B financing, adding an additional $3M from New ... Mesa Verde Venture Partners and other strategic partners at ... towards further accelerating commercial adoption of their flagship Paradigm ... and expanding the Paradigm cancer registry. ...
Breaking Biology Technology:
(Date:1/30/2017)... Jan. 30, 2017   Invitae Corporation (NYSE: ... genetic information companies, today announced that it will report ... provide 2017 guidance on Monday, February 13, 2017, and ... day at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... will briefly review financial results, guidance, and recent developments ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds ... baby,s sock that monitors vital signs and alerts ... an infant,s oxygen saturation level drops. But pediatric ... alarm to parents, with no evidence of medical ... devices are marketed aggressively to parents of healthy ...
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic ... to mergers and acquisitions (M&A), and Kalorama Information expects ... such acquisitions have been shifting. Generally, uncertainty in reimbursement ... and the U.S. has changed the acquisitions landscape. Instead ... resulted in companies buying partners outside of their home ...
Breaking Biology News(10 mins):